Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters

Hao Wei Shen, Yoko Hagino, Kidealci Kobayashi, Keiko Shinohara-Tanaka, Kazutaka Ikeda, Hideko Yamamoto, Toshifumi Yamamoto, Klaus Peter Lesch, Dennis L. Murphy, F. S. Hall, George R. Uhl, Ichiro Sora

Research output: Contribution to journalArticle

Abstract

Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DA ex) and serotonin (5-HT ex) levels in microdialysates from nucleus accumbens (NAc), caudate putamen (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double-KO mice, which are differentially rewarded by cocaine. Cocaine fails to increase DA ex in NAc of DAT-KO mice. By contrast, systemic cocaine enhances DA ex in both CPu and PFc of DAT-KO mice though local cocaine fails to affect DA ex in CPu. Adding SERT to DAT deletion attenuates the cocaine-induced DA ex increases found in CPu, but not those found in PFc. The selective SERT blocker fluoxetine increases DA ex in CPu of DAT-KO mice, while cocaine and the selective DAT blocker GBR12909 increase S-HT ex in CPu of SERT-KO mice. These data provide evidence that (a) cocaine increases DA ex in PFc independently of DAT and that (b), in the absence of SERT, CPu levels of 5-HT ex can be increased by blocking DAT. Cocaine-induced alterations in CPu DA levels in DAT-, SERT-, and DAT/SERT double-KO mice appear to provide better correlations with cocaine CPP than cocaine-induced DA level alterations in NAc or PFc.

Original languageEnglish (US)
Pages (from-to)1790-1799
Number of pages10
JournalNeuropsychopharmacology
Volume29
Issue number10
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Dopamine Plasma Membrane Transport Proteins
Microdialysis
Cocaine
Dopamine
Serotonin
Putamen
Knockout Mice
Prefrontal Cortex
Nucleus Accumbens
Dopamine Antagonists
Fluoxetine

Keywords

  • Cocaine reward
  • Dopamine
  • in vivo microdialysis
  • Knockout mice
  • Monoamine transporter
  • Serotonin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. / Shen, Hao Wei; Hagino, Yoko; Kobayashi, Kidealci; Shinohara-Tanaka, Keiko; Ikeda, Kazutaka; Yamamoto, Hideko; Yamamoto, Toshifumi; Lesch, Klaus Peter; Murphy, Dennis L.; Hall, F. S.; Uhl, George R.; Sora, Ichiro.

In: Neuropsychopharmacology, Vol. 29, No. 10, 10.2004, p. 1790-1799.

Research output: Contribution to journalArticle

Shen, HW, Hagino, Y, Kobayashi, K, Shinohara-Tanaka, K, Ikeda, K, Yamamoto, H, Yamamoto, T, Lesch, KP, Murphy, DL, Hall, FS, Uhl, GR & Sora, I 2004, 'Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters', Neuropsychopharmacology, vol. 29, no. 10, pp. 1790-1799. https://doi.org/10.1038/sj.npp.1300476
Shen, Hao Wei ; Hagino, Yoko ; Kobayashi, Kidealci ; Shinohara-Tanaka, Keiko ; Ikeda, Kazutaka ; Yamamoto, Hideko ; Yamamoto, Toshifumi ; Lesch, Klaus Peter ; Murphy, Dennis L. ; Hall, F. S. ; Uhl, George R. ; Sora, Ichiro. / Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. In: Neuropsychopharmacology. 2004 ; Vol. 29, No. 10. pp. 1790-1799.
@article{0378a416fed04ea28688ac09a654813c,
title = "Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters",
abstract = "Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DA ex) and serotonin (5-HT ex) levels in microdialysates from nucleus accumbens (NAc), caudate putamen (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double-KO mice, which are differentially rewarded by cocaine. Cocaine fails to increase DA ex in NAc of DAT-KO mice. By contrast, systemic cocaine enhances DA ex in both CPu and PFc of DAT-KO mice though local cocaine fails to affect DA ex in CPu. Adding SERT to DAT deletion attenuates the cocaine-induced DA ex increases found in CPu, but not those found in PFc. The selective SERT blocker fluoxetine increases DA ex in CPu of DAT-KO mice, while cocaine and the selective DAT blocker GBR12909 increase S-HT ex in CPu of SERT-KO mice. These data provide evidence that (a) cocaine increases DA ex in PFc independently of DAT and that (b), in the absence of SERT, CPu levels of 5-HT ex can be increased by blocking DAT. Cocaine-induced alterations in CPu DA levels in DAT-, SERT-, and DAT/SERT double-KO mice appear to provide better correlations with cocaine CPP than cocaine-induced DA level alterations in NAc or PFc.",
keywords = "Cocaine reward, Dopamine, in vivo microdialysis, Knockout mice, Monoamine transporter, Serotonin",
author = "Shen, {Hao Wei} and Yoko Hagino and Kidealci Kobayashi and Keiko Shinohara-Tanaka and Kazutaka Ikeda and Hideko Yamamoto and Toshifumi Yamamoto and Lesch, {Klaus Peter} and Murphy, {Dennis L.} and Hall, {F. S.} and Uhl, {George R.} and Ichiro Sora",
year = "2004",
month = "10",
doi = "10.1038/sj.npp.1300476",
language = "English (US)",
volume = "29",
pages = "1790--1799",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters

AU - Shen, Hao Wei

AU - Hagino, Yoko

AU - Kobayashi, Kidealci

AU - Shinohara-Tanaka, Keiko

AU - Ikeda, Kazutaka

AU - Yamamoto, Hideko

AU - Yamamoto, Toshifumi

AU - Lesch, Klaus Peter

AU - Murphy, Dennis L.

AU - Hall, F. S.

AU - Uhl, George R.

AU - Sora, Ichiro

PY - 2004/10

Y1 - 2004/10

N2 - Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DA ex) and serotonin (5-HT ex) levels in microdialysates from nucleus accumbens (NAc), caudate putamen (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double-KO mice, which are differentially rewarded by cocaine. Cocaine fails to increase DA ex in NAc of DAT-KO mice. By contrast, systemic cocaine enhances DA ex in both CPu and PFc of DAT-KO mice though local cocaine fails to affect DA ex in CPu. Adding SERT to DAT deletion attenuates the cocaine-induced DA ex increases found in CPu, but not those found in PFc. The selective SERT blocker fluoxetine increases DA ex in CPu of DAT-KO mice, while cocaine and the selective DAT blocker GBR12909 increase S-HT ex in CPu of SERT-KO mice. These data provide evidence that (a) cocaine increases DA ex in PFc independently of DAT and that (b), in the absence of SERT, CPu levels of 5-HT ex can be increased by blocking DAT. Cocaine-induced alterations in CPu DA levels in DAT-, SERT-, and DAT/SERT double-KO mice appear to provide better correlations with cocaine CPP than cocaine-induced DA level alterations in NAc or PFc.

AB - Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DA ex) and serotonin (5-HT ex) levels in microdialysates from nucleus accumbens (NAc), caudate putamen (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double-KO mice, which are differentially rewarded by cocaine. Cocaine fails to increase DA ex in NAc of DAT-KO mice. By contrast, systemic cocaine enhances DA ex in both CPu and PFc of DAT-KO mice though local cocaine fails to affect DA ex in CPu. Adding SERT to DAT deletion attenuates the cocaine-induced DA ex increases found in CPu, but not those found in PFc. The selective SERT blocker fluoxetine increases DA ex in CPu of DAT-KO mice, while cocaine and the selective DAT blocker GBR12909 increase S-HT ex in CPu of SERT-KO mice. These data provide evidence that (a) cocaine increases DA ex in PFc independently of DAT and that (b), in the absence of SERT, CPu levels of 5-HT ex can be increased by blocking DAT. Cocaine-induced alterations in CPu DA levels in DAT-, SERT-, and DAT/SERT double-KO mice appear to provide better correlations with cocaine CPP than cocaine-induced DA level alterations in NAc or PFc.

KW - Cocaine reward

KW - Dopamine

KW - in vivo microdialysis

KW - Knockout mice

KW - Monoamine transporter

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=5044225659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5044225659&partnerID=8YFLogxK

U2 - 10.1038/sj.npp.1300476

DO - 10.1038/sj.npp.1300476

M3 - Article

C2 - 15226739

AN - SCOPUS:5044225659

VL - 29

SP - 1790

EP - 1799

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 10

ER -